% Created 2018-05-23 Wed 13:43
\documentclass[presentation, smaller]{beamer}
\usepackage[utf8]{inputenc}
\usepackage[T1]{fontenc}
\usepackage{fixltx2e}
\usepackage{graphicx}
\usepackage{grffile}
\usepackage{longtable}
\usepackage{wrapfig}
\usepackage{rotating}
\usepackage[normalem]{ulem}
\usepackage{amsmath}
\usepackage{textcomp}
\usepackage{amssymb}
\usepackage{capt-of}
\usepackage{hyperref}
\hypersetup{colorlinks,linkcolor=gray,urlcolor=blue}
\usepackage{textpos}
\usepackage{textgreek}
\usepackage[version=4]{mhchem}
\usepackage{chemfig}
\usepackage{siunitx}
\usepackage{gensymb}
\usepackage[usenames,dvipsnames]{xcolor}
\usepackage[T1]{fontenc}
\usepackage{lmodern}
\usepackage{verbatim}
\usepackage{tikz}
\usetikzlibrary{shapes.geometric,arrows,decorations.pathmorphing,backgrounds,positioning,fit,petri}
\usetheme[height=20pt]{Boadilla}
\usecolortheme[RGB={170,160,80}]{{structure}}
\author{Matthew Henderson, PhD, FCACB}
\date{\today}
\title{Fasting Urine Organic Acids}
\institute[NSO]{Newborn Screening Ontario}
\titlegraphic{\includegraphics[height=1cm,keepaspectratio]{../logos/NSO_logo.pdf}\includegraphics[height=1cm,keepaspectratio]{../logos/cheo-logo.png} \includegraphics[height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}}
\hypersetup{
 pdfauthor={Matthew Henderson, PhD, FCACB},
 pdftitle={Fasting Urine Organic Acids},
 pdfkeywords={},
 pdfsubject={},
 pdfcreator={Emacs 25.2.1 (Org mode 8.3.4)}, 
 pdflang={English}}
\begin{document}

\maketitle

\logo{\includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/NSO_logo_small.pdf}}

\vspace{220pt}
\beamertemplatenavigationsymbolsempty
\setbeamertemplate{caption}[numbered]
\setbeamerfont{caption}{size=\tiny}
% \addtobeamertemplate{frametitle}{}{%
% \begin{textblock*}{100mm}(.85\textwidth,-1cm)
% \includegraphics[height=1cm,width=2cm]{cat}
% \end{textblock*}}


\tikzstyle{chemical} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=none]
\tikzstyle{hardware} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=gray!30]
\tikzstyle{ms} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{msw} = [rectangle, rounded corners, text width=7em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{label} = [rectangle,text width=8em, minimum height=1em, text centered, draw=none, fill=none]
\tikzstyle{hl} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=red!30]
\tikzstyle{box} = [rectangle, rounded corners, text width=5em, minimum height=5em,text centered, draw=black, fill=none]
\tikzstyle{arrow} = [thick,->,>=stealth]
\tikzstyle{hl-arrow} = [ultra thick,->,>=stealth,draw=red]

\section{Background}
\label{sec:orgheadline13}
\begin{frame}[label={sec:orgheadline1}]{Critical Sample}
\begin{itemize}
\item Abnormal urinary organic acid profiles of patients with FAOD may
occur only during acute episodes of hypoglycemia and/or fasting.

\begin{itemize}
\item plasma concentration of fatty acids increases, leading to an
elevated urinary excretion of medium-chain dicarboxylic acids.
\end{itemize}

\item Clinical notes refer to "Ketotic Hypoglycemia"

\item These medium-chain saturated metabolites usually include adipic
(DC6), suberic (DC8), and sebacic (DC10) acids?
\end{itemize}
\end{frame}

\begin{frame}[label={sec:orgheadline2}]{Fasting Urine Organic Acids}
\begin{itemize}
\item Many samples are sent from the ED or ICU in cases of prolonged
fasting, vomiting, dehydration.

\item Urine organic acid results include:
\begin{itemize}
\item lactate
\item urea
\item ketones
\item BCAA intermediate metabolites
\item dicarboxylic acids
\item NSAIDs
\end{itemize}
\end{itemize}
\end{frame}


\begin{frame}[label={sec:orgheadline3}]{Clinical History}
\begin{itemize}
\item a 5 yo female who had come to the ED twice in the last year with
vomiting, dehydration and hypoglycemia.

\item urine organic acids elevation in alpha-ketoacids 
\begin{itemize}
\item 2-ketoisocaproic
\item 2-ketoisovaleric
\item 2-keto-3-methylvaleric
\item urine creatinine = 4,113 umol/L
\end{itemize}

\item Plasma amino acids performed on a sample drawn at the same time
revealed a small elevation in BCAAs:
\begin{itemize}
\item Val = 608
\item Ile = 293
\item Leu = 484
\item Allo-Ile = 7
\end{itemize}

\item All amino acids and organic acids were normal in the convalescent
sample.

\item wondered if these results were due entirely to a profound fast or
are suggestive of intermediate MSUD.
\end{itemize}
\end{frame}

\begin{frame}[label={sec:orgheadline4}]{Fasting Profile}
\includegraphics[width=.9\linewidth]{./figures/fasting_rotate.png}
\end{frame}

\begin{frame}[label={sec:orgheadline5}]{Convalescent Profile}
\includegraphics[width=.9\linewidth]{./figures/convalescent_rotate.png}
\end{frame}

\begin{frame}[label={sec:orgheadline6}]{Glucose Sources with Fasting}
\includegraphics[width=.9\linewidth]{./figures/fasting_graph1.pdf}

\tiny
courtesy of SIMD-NAMA
\end{frame}

\begin{frame}[label={sec:orgheadline7}]{Energy Sources with Fasting}
\includegraphics[width=.9\linewidth]{./figures/fasting_graph2.pdf}

\tiny
courtesy of SIMD-NAMA
\end{frame}

\begin{frame}[label={sec:orgheadline8}]{Ketonuria}
\includegraphics[width=.9\linewidth]{./figures/ketones.png}

\begin{itemize}
\item Ketone bodies
\begin{itemize}
\item \(\beta\)-hydroxybutyric acid
\item acetoacetic acid
\end{itemize}
\end{itemize}
\end{frame}


\begin{frame}[label={sec:orgheadline9}]{Ketotic Hypoglycemia does not rule out an IMD}
\begin{itemize}
\item Other conditions which can present with ketotic hypoglycaemia are:
\begin{itemize}
\item FAOD: VLCADD, MCADD 
\begin{itemize}
\item inappropriately low ketones
\end{itemize}
\end{itemize}
\item intermediate form of MSUD
\item organic acidaemia: methylmalonic and isovaleric acidaemia
\item multiple carboxylase deficiency
\item defects of gluconeogenesis,
\begin{itemize}
\item such as glycogen storage disease type 1a
\end{itemize}
\end{itemize}
\end{frame}

\begin{frame}[label={sec:orgheadline10}]{Dicarboxylic Aciduria}
\begin{block}{Ketotic Dicarboxylic Aciduria.}
\begin{itemize}
\item Physiological response to hypoglycemia
\begin{itemize}
\item DC6 > DC8 > DC10
\end{itemize}
\end{itemize}
\end{block}

\begin{block}{Non-Ketotic Dicarboxylic Aciduria.}
\begin{itemize}
\item FAOD:
\begin{itemize}
\item DC6 > DC8 > DC10
\end{itemize}
\item MCAD + MCT
\begin{itemize}
\item DC10 > DC8 > DC6
\item or DC8 > DC10 > DC6 in some cases.
\end{itemize}

\item All fatty acid oxidation defects will permit production of ketones.
\end{itemize}
\end{block}
\end{frame}

\begin{frame}[label={sec:orgheadline11}]{BCAA metabolites}
\centering
\includegraphics[height=0.85\textheight]{./figures/bcaa.png}
\end{frame}

\begin{frame}[label={sec:orgheadline12}]{Dehydration}
\begin{itemize}
\item Urine Creatinine > 4,000 umol/L

\item 3-hydroxypropionic - PA
\item 3-hydroxyisovaleric - IVA
\item 3-methylglutaconic - 3-methylglutaconic aciduria
\end{itemize}
\end{frame}
\end{document}
